LYRA - Lyra Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LYRA is currently covered by 3 analysts with an average price target of $8.17. This is a potential upside of $7.97 (3985%) from yesterday's end of day stock price of $0.2.

Lyra Therapeutics 's activity chart (see below) currently has 4 price targets and 9 ratings on display. The stock rating distribution of LYRA is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for LYRA is $12, Lowest price target is $11, average price target is $8.17.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 01-May-2024. First documented stock forecast 26-May-2020.

Best performing analysts who are covering LYRA - Lyra Therapeutics :

Jason Gerberry Robert Hazlett Matthew Caufield

Currently out of the existing stock ratings of LYRA, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$7.97 (197.77%)

$12

9 months 12 days ago
(01-May-2024)

0/3 (0%)

$6.75 (128.57%)

Buy

$11

$6.97 (172.95%)

$15

10 months 19 days ago
(25-Mar-2024)

0/5 (0%)

$4.84 (78.57%)

Buy

$28

2 years 6 days ago
(07-Feb-2023)

0/1 (0%)

$12.31 (78.46%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LYRA (Lyra Therapeutics ) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JASON GERBERRY

Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?

Jason Gerberry works at BAML and has 5 price targets and 4 ratings on LYRA

Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?

Matthew Caufield with highest potential upside - $7.97

Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?

Robert Hazlett with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?